1 – 53 of 53
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis
(
- Contribution to journal › Article
- 2023
-
Mark
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease : A Retrospective Cohort Study
(
- Contribution to journal › Article
-
Mark
Food Processing and Risk of Crohn's Disease and Ulcerative Colitis : A European Prospective Cohort Study
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
(
- Contribution to journal › Article
- 2022
-
Mark
Obesity is Associated With Increased Risk of Crohn's disease, but not Ulcerative Colitis : A Pooled Analysis of Five Prospective Cohort Studies
(
- Contribution to journal › Article
-
Mark
Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases : A Nationwide Cohort Study
(
- Contribution to journal › Article
-
Mark
Meat intake is associated with a higher risk of ulcerative colitis in a large European prospective cohort study
(
- Contribution to journal › Article
-
Mark
Association Between Inflammatory Bowel Disease and Spondyloarthritis : Findings from a Nationwide Study in Sweden
(
- Contribution to journal › Article
- 2021
-
Mark
Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
(
- Contribution to journal › Article
-
Mark
Predictors of drug survival : A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register
(
- Contribution to journal › Article
-
Mark
Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population : a nationwide register-based cohort study 2002–2017
(
- Contribution to journal › Article
- 2020
-
Mark
The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register
(
- Contribution to journal › Article
-
Mark
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis : results from a nationwide study in Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatment
(
- Contribution to journal › Article
-
Mark
Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Inflammatory bowel disease registries for collection of patient iron parameters in Europe
(
- Contribution to journal › Scientific review
-
Mark
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
(
- Contribution to journal › Article
-
Mark
Clinical effectiveness of golimumab in Crohn’s disease : an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
(
- Contribution to journal › Article
-
Mark
Fibre intake and the development of inflammatory bowel disease : A European prospective multi-centre cohort study (EPIC-IBD)
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term outcome of infliximab treatment in chronic active ulcerative colitis : a Swedish multicentre study of 250 patients
(
- Contribution to journal › Article
-
Mark
Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC)
(
- Contribution to journal › Article
- 2016
-
Mark
Dairy products, dietary calcium, and risk of inflammatory bowel disease : Results from a European prospective cohort investigation
(
- Contribution to journal › Article
-
Mark
The protease inhibitor cystatin C downregulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes
(
- Contribution to journal › Article
-
Mark
Role of Monocytes and Intestinal Macrophages in Crohn's Disease and Ulcerative Colitis
(
- Contribution to journal › Scientific review
- 2015
-
Mark
A major population of mucosal memory CD4(+) T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.
(
- Contribution to journal › Article
-
Mark
A Single-Cell Gene-Expression Profile Reveals Inter-Cellular Heterogeneity within Human Monocyte Subsets.
(
- Contribution to journal › Article
-
Mark
Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study.
2015) In Inflammatory Bowel Diseases(
- Contribution to journal › Article
- 2014
-
Mark
Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease
(
- Contribution to journal › Article
-
Mark
CD14(hi) HLA-DRdim macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease
(
- Contribution to journal › Article
-
Mark
Carbohydrate Intake in the Etiology of Crohn's Disease and Ulcerative Colitis.
(
- Contribution to journal › Article
- 2013
-
Mark
Serological markers predict inflammatory bowel disease years before the diagnosis
(
- Contribution to journal › Article
-
Mark
Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study)
(
- Contribution to journal › Article
-
Mark
Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6C(hi) monocyte precursors
(
- Contribution to journal › Article
- 2011
-
Mark
Detection of Alzheimer peptides and chemokines in the aqueous humor
(
- Contribution to journal › Article
- 2010
-
Mark
Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo
(
- Contribution to journal › Article
-
Mark
Lymphocyte and monocyte flow cytometry immunophenotyping as a diagnostic tool in uncharacteristic inflammatory disorders.
(
- Contribution to journal › Article
-
Mark
The epidemiology and clinical features of portal vein thrombosis : A multicentre study
(
- Contribution to journal › Article
- 2009
-
Mark
Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience
(
- Contribution to journal › Article
-
Mark
Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study
(
- Contribution to journal › Article
-
Mark
Diagnosen IBD måste grundas på bred bas
(
- Contribution to journal › Article
-
Mark
Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.
(
- Contribution to journal › Article
- 2008
-
Mark
Diet in the aetiology of ulcerative colitis: A European prospective cohort study
(
- Contribution to journal › Article
-
Mark
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease
(
- Contribution to journal › Article
-
Mark
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: The first 100 patients treated in Scandinavia
(
- Contribution to journal › Article
- 2004
-
Mark
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin.
(
- Contribution to journal › Article
-
Mark
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease : Elevated oxidized low-density lipoprotein and the anti-inflammatory effect of artorvastatin
(
- Contribution to journal › Article
- 2003
-
Mark
On the regulation and effects of chronic inflammation in inflammatory bowel disease
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes.
(
- Contribution to journal › Article
-
Mark
Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes
(
- Contribution to journal › Article
- 2000
-
Mark
Increased presence of cells containing transforming growth factor alpha (TGF-alpha) in ulcerative colitis, both during active inflammation and in remission
(
- Contribution to journal › Article
-
Mark
Pravastatin down-regulates inflammatory mediators in human monocytes in vitro
(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease promotes venous thrombosis earlier in life
(
- Contribution to journal › Article